Boston Scientific Corp
(MIL:1BSX)
€
39.01
-0.17 (-0.42%)
Market Cap: 58.43 Bil
Enterprise Value: 67.05 Bil
PE Ratio: 18.73
PB Ratio: 2.57
GF Score: 63/100 Boston Scientific Corp at Bernstein Strategic Decisions Conference Transcript
May 27, 2026 / 12:00PM GMT
Release Date Price:
€44.71
(-10.06%)
Lee Hambright
Sanford C Bernstein & Co LLC - Analyst
All right. Hi, everybody.
Michael Mahoney
Boston Scientific Corp - Chairman of the Board, President, Chief Executive Officer
Morning, Lee.
Lee Hambright
Sanford C Bernstein & Co LLC - Analyst
Hi, everybody. I'm Lee Hambright, US medtech analyst at Bernstein. We're very pleased to kick off the strategic decision conference again with Boston Scientific. We've got Mike Mahoney, Chairman and CEO; and Ken Stein, Chief Medical Officer. Thanks so much guys for being here.
Michael Mahoney
Boston Scientific Corp - Chairman of the Board, President, Chief Executive Officer
Thank you for having us.
Lee Hambright
Sanford C Bernstein & Co LLC - Analyst
For those of you in the audience, if you have questions, we can -- you can enter them in the pigeon hole tool. I will try to work in as many as I can.
Mike, kicking off your 15th year at Boston Scientific and you
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot